LPL Financial LLC

Position in ROIV — Roivant Sciences Ltd.

CIK 1403438 FORT MILL, SC

Position in ROIV

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$11,833,566

+$1,344,795 QoQ

Shares Held

334,376

-11.7% QoQ

Ownership

0.046%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#98

of 494 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 2% Shared 0% None 98%

Healthcare · as of Jun 30, 2026

LPL Financial LLC holds $551,304,275 across 203 Biotechnology names. ROIV ranks #11 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	289,111	$143,610,107
2	REGN	Regeneron Pharmaceuticals, Inc.	65,755	$41,000,872
3	ARWR	Arrowhead Pharmaceuticals, Inc.	310,761	$25,330,129
4	ARGX	Argenx SE	19,499	$18,090,587
5	ALNY	Alnylam Pharmaceuticals, Inc.	57,890	$17,426,626
6	HALO	Halozyme Therapeutics, Inc.	203,557	$15,932,406
7	RPRX	Royalty Pharma plc	249,117	$13,967,990
8	INSM	INSMED Inc	128,553	$13,706,320

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,833,566	334,376	-11.7%	Shares	Sole	2026-08-07
2026-03-31	$10,488,771	378,656	+7.7%	Shares	Sole	2026-05-06
2025-12-31	$7,626,833	351,467	+213.2%	Shares	Sole	2026-02-11
2025-09-30	$1,697,888	112,220	+200.6%	Shares	Sole	2025-11-12
2025-06-30	$420,709	37,330	+85.4%	Shares	Sole	2025-08-12
2025-03-31	$203,131	20,132	-72.5%	Shares	Sole	2025-05-07
2024-12-31	$867,233	73,308	+11.3%	Shares	Sole	2025-02-11
2024-09-30	$759,978	65,856	+116.1%	Shares	Sole	2024-11-08
2024-06-30	$322,152	30,478	-20.9%	Shares	Sole	2024-08-07
2024-03-31	$406,211	38,540	+92.8%	Shares	Sole	2024-05-10
2023-12-31	$224,487	19,990	+83.2%	Shares	Sole	2024-02-14
2023-09-30	$127,428	10,910	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.